G3PP activators constitute a specialized group of chemical compounds that are designed to enhance the activity of the enzyme glycerol-3-phosphate phosphatase (G3PP). This enzyme plays a pivotal role in cellular metabolism by catalyzing the dephosphorylation of glycerol-3-phosphate to glycerol, thereby influencing the balance between lipid synthesis and carbohydrate metabolism. G3PP activators function by binding to the enzyme and increasing its catalytic efficiency, which can have a significant impact on the metabolic flux of glycerol and glucose within cells. The mechanisms by which these activators work can vary; they may induce conformational changes that stabilize the active form of the enzyme, enhance the enzyme's affinity for its substrate, or protect the enzyme from deactivation.
The discovery and development of G3PP activators often involve a complex interplay of biochemistry, structural biology, and organic chemistry. A deep understanding of the three-dimensional structure of G3PP is critical, as activators must interact precisely with the enzyme's active site or allosteric sites without affecting the overall stability of the protein. Structure-activity relationship studies are frequently employed to identify key functional groups or molecular frameworks that are essential for the activation of G3PP. Moreover, the design of these molecules must take into account the physicochemical properties that will enable them to reach the intracellular environment where G3PP is located. This includes optimizing their hydrophobicity, solubility, and stability to ensure that they can traverse cellular membranes and resist metabolic breakdown long enough to exert their activating effect. Ultimately, G3PP activators are crafted through iterative cycles of synthesis and testing, with the goal of obtaining molecules that exhibit high specificity and potency in modulating the activity of G3PP.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Activates AMP-activated protein kinase (AMPK), which can enhance glucose uptake and utilization, possibly leading to the activation of G3PP as part of cellular homeostasis. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Enhances insulin sensitivity and activates SIRT1, which may indirectly affect G3PP by altering glucose and lipid metabolism. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
An AMPK agonist that can mimic the cellular effects of exercise, possibly leading to enhanced G3PP activity through improved glucose regulation. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
A PPAR-gamma agonist that can improve insulin sensitivity and glucose uptake, which may have downstream effects on G3PP activity. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Another PPAR-gamma agonist that enhances insulin sensitivity, potentially affecting G3PP activity in glucose metabolism. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels which can modulate glucose metabolism, potentially leading to G3PP activation. | ||||||
α-Lipoic Acid | 1077-28-7 | sc-202032 sc-202032A sc-202032B sc-202032C sc-202032D | 5 g 10 g 250 g 500 g 1 kg | $69.00 $122.00 $212.00 $380.00 $716.00 | 3 | |
Improves insulin sensitivity and may influence G3PP activity through modulation of glucose metabolism. | ||||||
Ciglitazone | 74772-77-3 | sc-200902 sc-200902A | 5 mg 25 mg | $104.00 $428.00 | 10 | |
A PPAR-gamma agonist that could enhance insulin sensitivity and thus possibly impact G3PP activity indirectly. | ||||||
Chromium Picolinate | 14639-25-9 | sc-204685 sc-204685A | 5 g 25 g | $214.00 $667.00 | 1 | |
May improve insulin sensitivity and glucose metabolism, thereby potentially influencing G3PP activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
An isoflavone that can modulate insulin signaling and glucose metabolism, possibly affecting G3PP activity. | ||||||